The effect of FABP2 promoter haplotype on response to a diet with medium-chain triacylglycerols

[1]  J. Schrezenmeir,et al.  Association of postprandial and fasting triglycerides with traits of the metabolic syndrome in the Metabolic Intervention Cohort Kiel. , 2010, European journal of endocrinology.

[2]  L. Alhonen,et al.  Effect of medium‐ and long‐chain fatty acid diets on PPAR and SREBP‐1 expression and glucose homeostasis in ACBP‐overexpressing transgenic rats , 2008, Acta physiologica.

[3]  J. Schrezenmeir,et al.  Postprandial plasma adiponectin decreases after glucose and high fat meal and is independently associated with postprandial triacylglycerols but not with − 11388 promoter polymorphism , 2007, British Journal of Nutrition.

[4]  B. Corkey,et al.  Effects of dietary medium-chain triglyceride on weight loss and insulin sensitivity in a group of moderately overweight free-living type 2 diabetic Chinese subjects. , 2007, Metabolism: clinical and experimental.

[5]  S. Schreiber,et al.  The association of fatty acid-binding protein 2 A54T polymorphism with postprandial lipemia depends on promoter variability. , 2007, Metabolism: clinical and experimental.

[6]  J. Hampe,et al.  Association between functional FABP2 promoter haplotype and type 2 diabetes. , 2006, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[7]  J. López-Miranda,et al.  The Ala54Thr polymorphism of the fatty acid-binding protein 2 gene is associated with a change in insulin sensitivity after a change in the type of dietary fat. , 2005, The American journal of clinical nutrition.

[8]  Y. Obara,et al.  Octanoate stimulates cytosolic triacylglycerol accumulation and CD36 mRNA expression but inhibits Acetyl coenzyme A carboxylase activity in primary cultured bovine mammary epithelial cells , 2004, Journal of Dairy Research.

[9]  R. Hegele,et al.  Postprandial lipemia in subjects with the threonine 54 variant of the fatty acid-binding protein 2 gene is dependent on the type of fat ingested. , 2004, The American journal of clinical nutrition.

[10]  M. Jauhiainen,et al.  Effects of medium-chain fatty acids and oleic acid on blood lipids, lipoproteins, glucose, insulin, and lipid transfer protein activities. , 2004, The American journal of clinical nutrition.

[11]  L. Baier,et al.  Variation in the FABP2 promoter affects gene expression: implications for prior association studies , 2004, Diabetologia.

[12]  K. Kondo,et al.  Effects of margarine containing medium-chain triacylglycerols on body fat reduction in humans. , 2003, Journal of atherosclerosis and thrombosis.

[13]  R. Hamman,et al.  Variation in the FABP2 promoter alters transcriptional activity and is associated with body composition and plasma lipid levels , 2003, Human Genetics.

[14]  D. Lairon,et al.  Butter differs from olive oil and sunflower oil in its effects on postprandial lipemia and triacylglycerol-rich lipoproteins after single mixed meals in healthy young men. , 2002, The Journal of nutrition.

[15]  A. McIntosh,et al.  Liver Fatty Acid-binding Protein Targets Fatty Acids to the Nucleus , 2002, The Journal of Biological Chemistry.

[16]  N. Lynch,et al.  Detection of a Promoter Polymorphism in the Gene of Intestinal Fatty Acid Binding Protein (I‐FABP) , 2002, Annals of the New York Academy of Sciences.

[17]  J. Louis-Sylvestre,et al.  Substrate oxidation and control of food intake in men after a fat-substitute meal compared with meals supplemented with an isoenergetic load of carbohydrate, long-chain triacylglycerols, or medium-chain triacylglycerols. , 2001, The American journal of clinical nutrition.

[18]  E Chambers,et al.  Cognitive strategies for reporting portion sizes using dietary recall procedures. , 2000, Journal of the American Dietetic Association.

[19]  A. Kleinfeld,et al.  Fatty acid binding proteins from different tissues show distinct patterns of fatty acid interactions. , 2000, Biochemistry.

[20]  M. Passarelli,et al.  Dietary medium-chain triacylglycerol prevents the postprandial rise of plasma triacylglycerols but induces hypercholesterolemia in primary hypertriglyceridemic subjects. , 2000, The American journal of clinical nutrition.

[21]  N J Lynch,et al.  Linkage of inflammatory bowel disease to human chromosome 6p. , 1999, American journal of human genetics.

[22]  M. Laakso,et al.  Postprandial lipemic response is modified by the polymorphism at codon 54 of the fatty acid-binding protein 2 gene. , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[23]  P. Zimmet,et al.  Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO Consultation , 1998, Diabetic medicine : a journal of the British Diabetic Association.

[24]  M. Laville,et al.  Influence of human obesity on the metabolic fate of dietary long- and medium-chain triacylglycerols. , 1998, The American journal of clinical nutrition.

[25]  A. Yonemura,et al.  Olive oil increases the magnitude of postprandial chylomicron remnants compared to milk fat and safflower oil. , 1997, Journal of the American College of Nutrition.

[26]  R. Hegele,et al.  Intestinal fatty acid‐binding protein variation associated with variation in the response of plasma lipoproteins to dietary fibre , 1997, European journal of clinical investigation.

[27]  Rachel K. Johnson,et al.  Comparison of multiple-pass 24-hour recall estimates of energy intake with total energy expenditure determined by the doubly labeled water method in young children. , 1996, Journal of the American Dietetic Association.

[28]  Y. Ingenbleek,et al.  The usefulness of dietary medium-chain triglycerides in body weight control: fact or fancy? , 1996, Journal of lipid research.

[29]  C. Bogardus,et al.  An amino acid substitution in the human intestinal fatty acid binding protein is associated with increased fatty acid binding, increased fat oxidation, and insulin resistance. , 1995, The Journal of clinical investigation.

[30]  A. Kleinfeld,et al.  Equilibrium constants for the binding of fatty acids with fatty acid-binding proteins from adipocyte, intestine, heart, and liver measured with the fluorescent probe ADIFAB. , 1994, The Journal of biological chemistry.

[31]  R. Eckel,et al.  Dietary Substitution of Medium-Chain Triglycerides Improves Insulin-Mediated Glucose Metabolism in NIDDM Subjects , 1992, Diabetes.

[32]  J. Peters,et al.  Thermogenesis in humans during overfeeding with medium-chain triglycerides. , 1989, Metabolism: clinical and experimental.

[33]  J B Lowe,et al.  Expression of rat intestinal fatty acid-binding protein in Escherichia coli. Purification and comparison of ligand binding characteristics with that of Escherichia coli-derived rat liver fatty acid-binding protein. , 1987, The Journal of biological chemistry.

[34]  J C Stanley,et al.  The glucose-fatty acid cycle. Relationship between glucose utilization in muscle, fatty acid oxidation in muscle and lipolysis in adipose tissue. , 1981, British journal of anaesthesia.

[35]  H. Sarett,et al.  Medium-chain triglycerides. , 1968, JAMA.

[36]  E. Newsholme,et al.  The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. , 1963, Lancet.

[37]  M. Ball,et al.  Parenteral nutrition in the critically ill: Use of a medium chain triglyceride emulsion , 2005, Intensive Care Medicine.

[38]  G. L. Mills,et al.  A guidebook to lipoprotein technique , 1984 .

[39]  E. Work,et al.  Laboratory techniques in biochemistry and molecular biology , 1969 .